CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −5,387 | $85.00 | $458K | 7,933 |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −5,386 | $90.00 | $485K | 2,547 |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −1,590 | $85.00 | $135K | 3,180 |
| 2026-09-04 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −1,590 | $90.00 | $143K | 1,590 |
| 2026-09-02 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −5,387 | $80.00 | $431K | 13,320 |
| 2026-09-02 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −1,590 | $80.00 | $127K | 4,770 |
| 2026-09-01 | Lin Elizabeth Yeu Chief Medical Officer | Sale 10b5-1 | −4,601 | $73.86 | $340K | 18,707 |
| 2026-03-19 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −390 | $67.00 | $26K | 23,308 |
| 2026-03-18 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −379 | $68.71 | $26K | 23,698 |
| 2026-03-17 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −375 | $69.42 | $26K | 24,077 |
| 2026-03-15 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise | +2,511 | 24,452 | ||
| 2026-03-15 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise · Restricted Stock Units | −2,511 | 7,534 | ||
| 2026-03-05 | Lin Elizabeth Yeu Chief Medical Officer | Grant or award · Stock Option (right to buy) | +27,310 | 27,310 | ||
| 2026-03-05 | Lin Elizabeth Yeu Chief Medical Officer | Grant or award · Restricted Stock Units | +17,161 | 17,161 | ||
| 2025-12-16 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −2,078 | $79.50 | $165K | 21,941 |
| 2025-12-15 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise | +6,819 | 24,019 | ||
| 2025-12-15 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise · Restricted Stock Units | −6,819 | 20,459 | ||
| 2025-06-16 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −1,006 | $41.08 | $41K | 7,694 |
| 2025-06-13 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise | +3,350 | 8,700 | ||
| 2025-06-13 | Lin Elizabeth Yeu Chief Medical Officer | Option exercise · Restricted Stock Units | −3,350 | 0 |
Page 1 of 2 · 24 trades